Latest period
1.77B
YoY change
+0.1%
5Y CAGR
+1.2%
Peak year (2022)
1.78B
Latest annual
1.77B
Shares Outstanding history chart for AbbVie (ABBV) from 2009 to 2025
Latest: 1.77B
Shares Outstanding growth chart for AbbVie (ABBV) from 2009 to 2025
Latest: +0.1%
Shares Outstanding history table for AbbVie (ABBV) from 2009 to 2025
| 2025 | 1.77B | +0.1% | +1.00M | ||
| 2024 | 1.77B | 0.0% | 0 | ||
| 2023 | 1.77B | -0.3% | -5.00M | ||
| 2022 | 1.78B | +0.1% | +1.00M | ||
| 2021 | 1.78B | +6.2% | +104.00M | ||
| 2020 | 1.67B | +12.7% | +189.00M | ||
| 2019 | 1.48B | -4.0% | -62.00M | ||
| 2018 | 1.55B | -3.6% | -57.00M | ||
| 2017 | 1.60B | -1.7% | -28.00M | ||
| 2016 | 1.63B | -0.4% | -6.00M | ||
| 2015 | 1.64B | +1.7% | +27.00M | ||
| 2014 | 1.61B | +0.4% | +6.00M | ||
| 2013 | 1.60B | +1.7% | +27.00M | ||
| 2012 | 1.58B | -3.0% | -48.00M | ||
| 2011 | 1.63B | 0.0% | 0 | ||
| 2010 | 1.63B | 0.0% | 0 | ||
| 2009 | 1.63B | — | — |
- 20251.77B+0.1%
- 20241.77B0.0%
- 20231.77B-0.3%
- 20221.78B+0.1%
- 20211.78B+6.2%
- 20201.67B+12.7%
- 20191.48B-4.0%
- 20181.55B-3.6%
- 20171.60B-1.7%
- 20161.63B-0.4%
- 20151.64B+1.7%
- 20141.61B+0.4%
- 20131.60B+1.7%
- 20121.58B-3.0%
- 20111.63B0.0%
- 20101.63B0.0%
- 20091.63B—
Shares Outstanding values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.77B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted shares outstanding for AbbVie (ABBV) came in at 1.77B – edged up 0.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AbbVie diluted shares outstanding compounded at +1.2% per year, with mixed annual results across the window.
The highest annual diluted shares outstanding of 1.78B was reported in 2022. The lowest in the available history was 1.48B in 2019.
AbbVie Shares Outstanding by Year
AbbVie Shares Outstanding 2025: 1.77B
2025's diluted shares outstanding for AbbVie came in at 1.77B, edged up 0.1% from 2024.
AbbVie Shares Outstanding 2024: 1.77B
AbbVie posted diluted shares outstanding of 1.77B in 2024, edged up 0.0% from 2023.
AbbVie Shares Outstanding 2023: 1.77B
In 2023, AbbVie reported diluted shares outstanding of 1.77B, edged down 0.3% below 2022.
AbbVie Shares Outstanding 2022: 1.78B
AbbVie diluted shares outstanding in 2022 was 1.78B, edged up 0.1% from 2021. This figure represents the highest annual value in the available history.
AbbVie Shares Outstanding 2021: 1.78B
AbbVie diluted shares outstanding in 2021 was 1.78B.
See more financial history for AbbVie (ABBV).
Sector peers by Shares Outstanding
Healthcare peers of AbbVie (ABBV), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M | |
| 377.00M |
- 4.45B
- 2.51B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation